Immuron Ltd. Files December 2025 6-K Report

Ticker: IMRN · Form: 6-K · Filed: Dec 10, 2025 · CIK: 1660046

Immuron LTD 6-K Filing Summary
FieldDetail
CompanyImmuron LTD (IMRN)
Form Type6-K
Filed DateDec 10, 2025
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: regulatory-filing, foreign-private-issuer

TL;DR

Immuron Ltd. filed its Dec 2025 6-K, confirming foreign private issuer status and 20-F filing for annual reports.

AI Summary

On December 10, 2025, Immuron Ltd. filed a Form 6-K with the SEC, reporting information for the month of December 2025. The filing indicates that Immuron Limited is a foreign private issuer and will file its annual reports under Form 20-F. The company's principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, Australia.

Why It Matters

This filing provides an update on Immuron Ltd.'s regulatory reporting status and confirms its classification as a foreign private issuer, which impacts its disclosure requirements with the SEC.

Risk Assessment

Risk Level: low — This is a routine filing for a foreign private issuer and does not contain significant new financial or operational information that would immediately impact the company's risk profile.

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing by Immuron Ltd.?

The Form 6-K is a report of a foreign private issuer for the month of December 2025, providing information to the SEC.

Does Immuron Ltd. file annual reports under Form 20-F or Form 40-F?

Immuron Ltd. indicates it files annual reports under cover of Form 20-F.

Is Immuron Ltd. furnishing information under Rule 12g3-2(b)?

No, Immuron Ltd. is not furnishing information under Rule 12g3-2(b) as indicated by the 'No' checkbox.

Where is Immuron Ltd.'s principal executive office located?

Immuron Ltd.'s principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.

What is the Commission File Number for Immuron Ltd.?

The Commission File Number for Immuron Ltd. is 001-38104.

Filing Stats: 314 words · 1 min read · ~1 pages · Grade level 17.4 · Accepted 2025-12-09 20:31:36

Filing Documents

From the Filing

OF FOREIGN PRIVATE ISSUER UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of December 2025 Commission File Number: 001-38104 IMMURON LIMITED (Name of Registrant) Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes No If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- IMMURON LIMITED EXPLANATORY NOTE Immuron Limited (the “Company”) published one announcement (the “Public Notices”) to the Australian Securities Exchange on December 10, 2025 titled: 99.1 Uniformed Services University to Release Topline Data A copy of the Public Notice is attached as an exhibit to this report on Form 6-K. This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. 1 EXHIBITS Exhibit Number Description 99.1 Uniformed Services University to Release Topline Data 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMURON LIMITED Date: December 10, 2025 By: /s/ Phillip Hains Phillip Hains Company Secretary 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing